Molecular engineering solutions for therapeutic peptide delivery
- PMID: 28902203
- DOI: 10.1039/c7cs00536a
Molecular engineering solutions for therapeutic peptide delivery
Abstract
Proteins and their interactions in and out of cells must be well-orchestrated for the healthy functioning and regulation of the body. Even the slightest disharmony can cause diseases. Therapeutic peptides are short amino acid sequences (generally considered <50 amino acids) that can naturally mimic the binding interfaces between proteins and thus, influence protein-protein interactions. Because of their fidelity of binding, peptides are a promising next generation of personalized medicines to reinstate biological harmony. Peptides as a group are highly selective, relatively safe, and biocompatible. However, they are also vulnerable to many in vivo pharmacologic barriers limiting their clinical translation. Current advances in molecular, chemical, and nanoparticle engineering are helping to overcome these previously insurmountable obstacles and improve the future of peptides as active and highly selective therapeutics. In this review, we focus on self-assembled vehicles as nanoparticles to carry and protect therapeutic peptides through this journey, and deliver them to the desired tissue.
Similar articles
-
Protein nanoparticles for therapeutic protein delivery.Biomater Sci. 2015 Jun;3(6):787-99. doi: 10.1039/c5bm00052a. Epub 2015 May 13. Biomater Sci. 2015. PMID: 26221839
-
Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.Nanomedicine (Lond). 2007 Apr;2(2):183-202. doi: 10.2217/17435889.2.2.183. Nanomedicine (Lond). 2007. PMID: 17716120 Review.
-
Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery.Peptides. 2010 Jan;31(1):184-93. doi: 10.1016/j.peptides.2009.10.002. Epub 2009 Oct 9. Peptides. 2010. PMID: 19819278 Review.
-
Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation.Peptides. 2011 Jan;32(1):173-87. doi: 10.1016/j.peptides.2010.10.003. Epub 2010 Oct 8. Peptides. 2011. PMID: 20934475 Review.
-
Drug carriers for the delivery of therapeutic peptides.Biomacromolecules. 2014 Apr 14;15(4):1097-114. doi: 10.1021/bm500169p. Epub 2014 Mar 24. Biomacromolecules. 2014. PMID: 24661025 Review.
Cited by
-
Effect of Pollyallylamine on Alcoholdehydrogenase Structure and Activity.Polymers (Basel). 2020 Apr 6;12(4):832. doi: 10.3390/polym12040832. Polymers (Basel). 2020. PMID: 32268489 Free PMC article.
-
A nanohybrid synthesized by polymeric assembling Au(I)-peptide precursor for anti-wrinkle function.Front Bioeng Biotechnol. 2022 Dec 12;10:1087363. doi: 10.3389/fbioe.2022.1087363. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36578506 Free PMC article.
-
A lanthanide-peptide-derived bacterium-like nanotheranostic with high tumor-targeting, -imaging and -killing properties.Biomaterials. 2019 Jun;206:13-24. doi: 10.1016/j.biomaterials.2019.03.026. Epub 2019 Mar 21. Biomaterials. 2019. PMID: 30921731 Free PMC article.
-
Trends in peptide drug discovery.Nat Rev Drug Discov. 2021 Apr;20(4):309-325. doi: 10.1038/s41573-020-00135-8. Epub 2021 Feb 3. Nat Rev Drug Discov. 2021. PMID: 33536635
-
pH-responsive high stability polymeric nanoparticles for targeted delivery of anticancer therapeutics.Commun Biol. 2020 Mar 3;3(1):95. doi: 10.1038/s42003-020-0817-4. Commun Biol. 2020. PMID: 32127636 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources